Marketing-authorisation holder · Spain
Janssen Cilag Pharmaceutical S.A.C.I.
8 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Spain
8 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| PARIET 20 MG COMPRIMIDOS GASTRORRESISTENTES20 mg · Comprimido gastrorresistente | Rabeprazole | Spain | Authorised | 2026 |
| PARIET 20 mg COMPRIMIDOS GASTRORRESISTENTES20 mg · Comprimido gastrorresistente | Rabeprazole | Spain | Authorised | 2026 |
| PARIET 20 MG COMPRIMIDOS GASTRORRESISTENTES20 mg · Comprimido gastrorresistente | Rabeprazole | Spain | Marketed | 2026 |
| PARIET 20 mg COMPRIMIDOS GASTRORRESISTENTES20 mg · Comprimido gastrorresistente | Rabeprazole | Spain | Marketed | 2025 |
| PARIET 20 MG COMPRIMIDOS GASTRORRESISTENTES20 mg · Comprimido gastrorresistente | Rabeprazole | Spain | Marketed | 2024 |
| REMINYL 16 mg CAPSULAS DURAS DE LIBERACION PROLONGADA20,51 mg · Cápsula dura de liberación prolongada | Galantamine | Spain | Authorised | 2022 |
| REMINYL 24 MG CAPSULAS DURAS DE LIBERACION PROLONGADA24 mg · Cápsula dura de liberación prolongada | Galantamine | Spain | Authorised | 2021 |
| REMINYL 24 MG CAPSULAS DURAS DE LIBERACION PROLONGADA30,76 mg · Cápsula dura de liberación prolongada | Galantamine | Spain | Marketed | 2025 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 8 | 8 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.